Cargando…
Drug‐Primed Self‐Assembly of Platinum‐Single‐Atom Nanozyme to Regulate Cellular Redox Homeostasis Against Cancer
Single‐atom nanozymes (SAzymes) with high catalytic activity exhibit the potential to disequilibrate the reactive oxygen metabolic balance in the tumor microenvironment (TME), which contains several endogenous reductive substances such as glutathione (GSH). Herein, a novel nano‐assembly (CDs@Pt SAs/...
Autores principales: | Zhang, Li, Dong, Qian, Hao, Yumin, Wang, Zihan, Dong, Wenjuan, Liu, Yang, Dong, Yueping, Wu, Hongpeng, Shuang, Shaomin, Dong, Chuan, Chen, Zhuo, Gong, Xiaojuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602509/ https://www.ncbi.nlm.nih.gov/pubmed/37697645 http://dx.doi.org/10.1002/advs.202302703 |
Ejemplares similares
-
Single-atom nanozymes
por: Huang, Liang, et al.
Publicado: (2019) -
Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation
por: Li, Qing, et al.
Publicado: (2021) -
Atomic engineering of single-atom nanozymes for enzyme-like catalysis
por: Wu, Weiwei, et al.
Publicado: (2020) -
Progress and perspectives of platinum nanozyme in cancer therapy
por: Wang, Xi, et al.
Publicado: (2022) -
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
por: Wang, Dongdong, et al.
Publicado: (2020)